Call us now !
Send us an email
Find us on the map
Bridge to Biologics
MCRs Custom Solutions
Safety & Regulations
1g,5g,10g,25g,50g and 100g
Store at 2-8 °C temperature
O-(2-(vinyloxy)ethyl)hydroxylamine is a pharmaceutially important intermediate for synthesis of various heterocyclic compounds as mitogen-activated protein kinase MEK inhibitors.
Potent and selective mitogen-activated protein kinase kinase(MEK)1,2 inhibitors. 1.4-(4-bromo-2-fluorophenylamino)-1-methylpyridin-2(1H)-ones.
Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors
Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions
Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479.
 E.M.Wallace, et al, J. Med. Chem.,
, 49(2), pp 441-444.
 M.B.Wallace, et al, Bioorg. Med. Chem.,
, 20(14), pp 4156-4158.
 R.A.Heald, et al, J. Med. Chem.,
, 55(10), pp 4594-4604.
 K.D.Robarge,, et al, Bioorg. Med. Chem.,
, 24(19), pp 4714-4723.
Not a dangerous goods
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email to
Copyright © 2020 Kumidas SA. All Rights Reserved.
Reproduction of any materials from this site is strictly forbidden without permission.